167 results on '"Scott, Peter J. H."'
Search Results
2. Recent advances and impending challenges for the radiopharmaceutical sciences in oncology
3. Differential cholinergic systems’ changes in progressive supranuclear palsy versus Parkinson’s disease: an exploratory analysis
4. Cholinergic brain network deficits associated with vestibular sensory conflict deficits in Parkinson’s disease: correlation with postural and gait deficits
5. C–H Labeling with [18F]Fluoride: An Emerging Methodology in Radiochemistry.
6. Automated radiosynthesis and preclinical imaging of a novel [18F]fluorolidocaine analogue via sequential C–H radiolabelling.
7. 3AcFNP-59 for Positron Emission Tomography Imaging of Cholesterol Trafficking and Utilization.
8. Room-Temperature Photochemical Copper-Mediated Fluorination of Aryl Iodides.
9. Preclinical evaluation of (S)-[18F]GE387, a novel 18-kDa translocator protein (TSPO) PET radioligand with low binding sensitivity to human polymorphism rs6971
10. Automated Radiosynthesis of [ 18 F]FluoFAPI and Its Dosimetry and Single Acute Dose Toxicological Evaluation.
11. Improved Radiosynthesis and Automation of [11C]2‐(2,6‐Difluoro‐4‐((2‐(N‐methylphenylsulfonamido)ethyl)thio)phenoxy)acetamide ([11C]K2) for Positron Emission Tomography of the Glutamate α‐Amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole Propionic Acid (AMPA) Receptor
12. Automated production of 11C‐labeled carboxylic acids and esters via "in‐loop" 11C‐carbonylation using GE FX synthesis modules.
13. Synthesis of high-molar-activity [18F]6-fluoro-l-DOPA suitable for human use via Cu-mediated fluorination of a BPin precursor
14. Combining Nuclear Medicine With Other Modalities: Future Prospect for Multimodality Imaging.
15. Photo- and Cu-Mediated 11C Cyanation of (Hetero)Aryl Thianthrenium Salts.
16. Cyclotron-based production of 68Ga, [68Ga]GaCl3, and [68Ga]Ga-PSMA-11 from a liquid target
17. Use of 55 PET radiotracers under approval of a Radioactive Drug Research Committee (RDRC)
18. Zinc‐Mediated Radiosynthesis of Unprotected Fluorine‐18 Labelled α‐Tertiary Amides.
19. Radiochemistry: A Hot Field with Opportunities for Cool Chemistry.
20. GABA A Receptor Benzodiazepine Binding Sites and Motor Impairments in Parkinson's Disease.
21. Ethical Considerations for Artificial Intelligence in Medical Imaging: Data Collection, Development, and Evaluation.
22. C–H radiocyanation of bioactive molecules via sequential iodination/copper-mediated cross-coupling.
23. Proceedings of international symposium of trends in radiopharmaceuticals 2023 (ISTR-2023).
24. An updated radiosynthesis of [18F]AV1451 for tau PET imaging
25. Development and implementation of ISAR, a new synthesis platform for radiopharmaceutical production
26. Cholinergic system correlates of postural control changes in Parkinson's disease freezers.
27. Applications of radiolabeled antibodies in neuroscience and neuro‐oncology.
28. Futureproofing [18F]Fludeoxyglucose manufacture at an Academic Medical Center
29. Room-Temperature Copper-Mediated Radiocyanation of Aryldiazonium Salts and Aryl Iodides via Aryl Radical Intermediates.
30. Highlight selection of radiochemistry and radiopharmacy developments by editorial board.
31. SNMMI Clinical Trial Network Research Series for Technologists: Application of Good Clinical Practice to Clinical Research in Medical Imaging.
32. Strategies for the Production of [11C]LY2795050 for Clinical Use.
33. Preparation and Evaluation of 64 Cu-Radiolabled Dual-Ligand Multifunctional Gold Nanoparticles for Tumor Theragnosis.
34. Progression of regional cortical cholinergic denervation in Parkinson's disease.
35. Development of Fluorinated NP-59: A Revival of Cholesterol Use Imaging with PET.
36. Frequency of Cholinergic and Caudate Nucleus Dopaminergic Deficits Across the Predemented Cognitive Spectrum of Parkinson Disease and Evidence of Interaction Effects
37. Classics in Neuroimaging: Untangling the Role of Tau in Neurodegenerative Disorders Using Positron Emission Tomography.
38. Proceedings: PET Drugs: A Workshop on Inspections Management and Regulatory Considerations.
39. SNMMI Clinical Trials Network Research Series for Technologists: Clinical Research Primer--Use of Imaging Agents in Therapeutic Drug Development and Approval.
40. Radiosynthesis and In Vivo Evaluation of Four Positron Emission Tomography Tracer Candidates for Imaging of Melatonin Receptors.
41. Copper-Mediated Radiocyanation of Unprotected Amino Acids and Peptides.
42. No Dopamine Agonist Modulation of Brain [18F]FEOBV Binding in Parkinson's Disease.
43. Synthesis of 68Ga-radiopharmaceuticals using both generator-derived and cyclotron-produced 68Ga as exemplified by [68Ga]Ga-PSMA-11 for prostate cancer PET imaging.
44. Preclinical evaluation of (S)-[18F]GE387, a novel 18-kDa translocator protein (TSPO) PET radioligand with low binding sensitivity to human polymorphism rs6971.
45. Synthesis and Evaluation of a Fluorine-18 Radioligand for Imaging Huntingtin Aggregates by Positron Emission Tomographic Imaging.
46. PSMA PET validates higher rates of metastatic disease for European Association of Urology Biochemical Recurrence Risk Groups: an international multicentre study.
47. Nuclear Medicine and Artificial Intelligence: Best Practices for Algorithm Development.
48. A comprehensive assessment of 68Ga-PSMA-11 PET in biochemically recurrent prostate cancer: Results from a prospective multi-center study in 2005 patients.
49. A comprehensive assessment of 68Ga-PSMA-11 PET in biochemically recurrent prostate cancer: Results from a prospective multi-center study in 2005 patients.
50. SNAr Radiofluorination with In Situ Generated [18F]Tetramethylammonium Fluoride.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.